Over-night Effect of Dietary Fiber on Glucose Metabolism and Satiety
Early Phase 1
Completed
- Conditions
- ObesityMetabolic Syndrome
- Registration Number
- NCT02347293
- Lead Sponsor
- Lund University
- Brief Summary
The experimental model is a semi-acute, over-night, study where the purpose is to evaluate food factors related to colonially derived regulation and satiety in healthy subjects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
- Normal fasting blood glucose
- BMI 19-25 kg/m2
Exclusion Criteria
- Gastrointestinal diseases
- Food allergies e.g. lactose-, gluten intolerance
- Metabolic disorder e.g. diabetes
- Tobacco/snuff users
- No antibiotic or probiotic intake 2 weeks prior and during study.
- Vegetarians
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Appetite hormones, levels of Peptide YY (PYY) in blood Postprandial 0-180 min after breakfast Insulin, levels of insulin in blood Postprandial 0-180 min after breakfast Markers of colonic fermentation, levels of hydrogen in breath Postprandial 0-180 min after breakfast Inflammation markers, levels of Interleukin-6 (IL-6) in blood Postprandial 0-180 min after breakfast Blood Glucose, levels of glucose in blood Postprandial 0-180 min after breakfast
- Secondary Outcome Measures
Name Time Method Subjective satiety, as measured by VAS Postprandial 0-180 min after breakfast
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link indigestible carbohydrates to improved glucose metabolism in metabolic syndrome patients?
How does colonic fermentation of dietary fiber compare to standard-of-care treatments for obesity in modulating satiety hormones?
Which gut microbiota-derived biomarkers predict metabolic response to overnight fiber intervention in NCT02347293?
What are the potential adverse events associated with high-dose indigestible carbohydrate supplementation in healthy individuals?
How do prebiotic fibers in NCT02347293 interact with short-chain fatty acid receptors to influence insulin sensitivity?
Trial Locations
- Locations (1)
Medicon Village
🇸🇪Lund, Sweden
Medicon Village🇸🇪Lund, Sweden